Blood cancer
Contact
- General Enquiries
- 020 3311 1234
Visitor Information
Visiting restrictions are in place. Please call the ward to find out more. Find your hospital ward contact information:
About
Our blood cancer service offers specialist care for all malignant blood diseases including acute and chronic leukaemias, lymphoma, myelodysplasia, myeloproliferative disorders and myeloma. We have a world-renowned stem cell transplant unit, specialising in transplantation for bone marrow failure, acute leukaemia, myeloma, lymphomas and solid tumours.
In 1975 we became one of the first hospitals in Europe to perform allogeneic stem cell transplant (when stem cells are transferred from one person to another) and remain one of the largest and most experienced centres worldwide. Our programme is one of the largest and most innovative in Europe, and is supported by a state-of-the-art facility for cell collection and manipulation. We are accredited by the Human Tissue Authority (HTA), the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the Medicines and Health Regulatory Agency (MHRA).
Conditions and treatments
Our service offers treats malignant blood conditions including:
- malignant blood diseases (acute and chronic leukaemias)
- lymphoma
- myelodysplasia
- myeloproliferative disorders
- myeloma
- bone marrow failure
- acute leukaemia and solid tumours
Additional information
Clinical trials and research
We actively participate in clinical trials, trying to bring the newest treatments to our patients in the safest possible way. For many years we have been leaders in drug development in leukaemia, particularly in chronic myeloid leukaemia (CML) and more recently in chronic lymphocytic leukaemia (CLL), myeloproliferative disorders (MPD) and myeloma. The clinical trials unit is currently based in the Catherine Lewis Centre and employs dedicated research nurses and trial co-ordinators. Our research colleagues obtain support for their work from the world’s leading funders of research, including the European Union, the Medical Research Council, the Wellcome Trust, Cancer Research UK, Bloodwise (previously Leukaemia and Lymphoma Research), Gabrielle’s Angels, Kay Kendall Research Foundation, the British Society of Haematology and the Blood Fund at Imperial Health Charity. We are a designated Bloodwise Centre of Excellence.
Education
If you are interested in an elective placement with our service, please contact imperial.Electives@nhs.net.
Latest news See all news
-
Read the full storyUltrasound scan can diagnose prostate cancer
An ultrasound scan can be used to detect cases of prostate cancer, according to new research by Imperial College London, University College London and Imperial College Healthcare NHS Trust. The study found that a new type of ultrasound scan can…
-
Read the full storyMRI tool that can diagnose difficult cases of ovarian cancer to be tested at the Trust
Imperial College Healthcare NHS Trust is going to be part of a major trial that will evaluate a new MRI tool for diagnosing ovarian cancer. The new tool can identify cases of ovarian cancer which are difficult to diagnose using standard methods and…
-
Read the full storyPioneering software set to improve NHS imaging services across north west London
Imperial College Healthcare is one of six NHS trusts in north west London that have formed a new network to improve imaging services – including x-ray, MRI and CT scans – to enable better care for cancer, stroke and a wide range of other conditions.